Total cholesterol 0.5 (-7.4, 8.4) 1.6 (-6.4, 9.6) 1.5 (-6.5, 9.6) 1.5 (-6.6, 9.5) 1.4 (-6.7, 9.6) ApoB 1.4 (-3.8, 6.6) 1.7 (-3.6, 6.9) 1.5 (-3.8, 6.9) 0.6 (-4.7, 5.9) 0.5 (-4.8, 5.8) CRP 4.7 (-13.4, 26.6) 1.9 (-15.9, 23.5) 2.4 (-15.6, 24.4) -7.8 (-22.7, 10 .0) -7.1 (-22.2, 11.0) a Women with a time-to-pregnancy > 12 months b Associations are expressed as the % difference in the geometric mean for log n -transformed outcomes (mg/dL triglycerides and mg/L CRP) or the difference in mean values (mg/dL of HDL-C, LDL-C, total cholesterol, and apoB) in the exposed compared with the unexposed group.
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Supplemental Material, Figure S1 . Directed acyclic graph for the selection of confounders when assessing the association of in utero exposure to tobacco smoke with plasma lipids, apolipoprotein B, and CRP among adult women from the MoBa cohort Variables connected by an arrow with a question mark, represents the association of interest.
Variables from the mother (in dotted rectangles) were potential confounders that were unmeasured (U). This DAG represents an oversimplification of the potential association of in utero exposure to tobacco smoke with the outcomes. 
